PortfoliosLab logoPortfoliosLab logo
ISIN
US7444131053
CUSIP
744413105
IPO Date
Apr 6, 2021

Highlights

Market Cap
$32.20M
Enterprise Value
$120.41M
EPS (TTM)
-$23.26
Total Revenue (TTM)
$1.47B
Gross Profit (TTM)
$269.01M
EBITDA (TTM)
-$176.39M
Year Range
$1.52 - $16.89
Target Price
$4.00
ROA (TTM)
-21.72%
ROE (TTM)
102.00%
Avg. Volume (1M)
26K
Avg. Volume Value (1M)
$266.43K

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


P3 Health Partners Inc.

Performance

PIII Performance Chart

P3 Health Partners Inc. (PIII) is up 181.7% since the beginning of the year. At $10 per share, PIII is trading 41.8% below its 52-week high of $17. Investors who bought $1,000 worth of PIII shares 5 years ago would now be looking at an investment worth $20.


Loading charts...

Benchmark

Compare this symbol against anything

Returns By Period

P3 Health Partners Inc. (PIII) has returned 181.66% so far this year and 33.74% over the past 12 months.


P3 Health Partners Inc.

1D
-3.82%
1M
-13.54%
6M
411.98%
YTD
181.66%
1Y
33.74%
3Y*
-55.36%
5Y*
-54.30%
10Y*
ALL TIME*
-52.24%

Benchmark (S&P 500 Index)

1D
0.70%
1M
0.09%
6M
7.94%
YTD
9.41%
1Y
20.07%
3Y*
17.84%
5Y*
11.25%
10Y*
13.26%
ALL TIME*
8.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PIII Monthly Returns History

Based on dividend-adjusted daily data since Apr 6, 2021, PIII's average daily return is -0.05%, while the average monthly return is +1.23%. At this rate, an investment would double in approximately 4.7 years.

Historically, 31% of months were positive and 69% were negative. The best month was May 2026 with a return of +339.7%, while the worst month was Dec 2022 at -61.5%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 6 months.

On a daily basis, PIII closed higher 43% of trading days. The best single day was May 15, 2026 with a return of +180.2%, while the worst single day was Nov 13, 2024 at -36.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-44.99%10.42%45.28%-10.06%339.71%-11.33%-8.98%181.66%
2025-19.79%4.77%-13.17%9.57%-17.80%-14.75%17.78%12.26%7.39%-2.18%-38.29%-35.37%-68.96%
2024-14.18%-14.05%-0.96%-47.84%-6.55%-10.30%39.91%-19.89%-23.46%-7.09%-30.34%-10.04%-84.05%
2023-29.89%-6.98%-11.67%19.81%218.90%-26.17%-25.75%-10.81%-25.76%-2.72%-16.08%17.50%-23.37%
2022-24.29%5.07%39.64%-22.38%-20.92%-22.50%31.99%0.20%-6.10%7.14%-3.43%-61.51%-73.86%
2021-2.10%1.33%-0.30%-0.30%-0.30%0.31%1.22%-1.40%-28.46%-29.60%

Benchmark Metrics

P3 Health Partners Inc. has an annualized alpha of -16.47%, beta of 0.50, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since April 06, 2021.

  • This stock participated in 227.90% of S&P 500 Index downside but only -31.27% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.50 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-16.47%
Beta
0.50
0.00
Upside Capture
-31.27%
Downside Capture
227.90%

Return for Risk

Risk / Return Rank

PIII ranks 65 for risk / return — above 65% of stocks peers on PortfoliosLab. Its historical combined result is above most peers.


PIII Risk / Return Rank: 6565
Overall Rank
PIII Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
PIII Sortino Ratio Rank: 8585
Sortino Ratio Rank
PIII Omega Ratio Rank: 8282
Omega Ratio Rank
PIII Calmar Ratio Rank: 5454
Calmar Ratio Rank
PIII Martin Ratio Rank: 5252
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

Risk / Return Metrics

The table below present risk-adjusted performance metrics for P3 Health Partners Inc. (PIII) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PIIIBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.27

Sortino ratioReturn per unit of downside risk

+0.38

Omega ratioGain probability vs. loss probability

1.28

1.25

+0.03

Calmar ratioReturn relative to maximum drawdown

0.38

2.00

-1.62

Martin ratioReturn relative to average drawdown

0.64

8.49

-7.85

Dividends

Dividend History


P3 Health Partners Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the P3 Health Partners Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the P3 Health Partners Inc. was 99.73%, occurring on Feb 2, 2026. The portfolio has not yet recovered.

The current P3 Health Partners Inc. drawdown is 98.28%.


Drawdown

Fall

Recovery

Underwater

Related event

-99.73%Feb 2026
4y 1mo
4y 7moDec 2021 - now
-12.64%Dec 2021
1d3d
3dDec 2021 - Dec 2021
-11.50%Dec 2021
5mo 13d5d
5mo 18dJun 2021 - Dec 2021
-3.40%May 2021
1mo 14d29d
2mo 13dApr 2021 - Jun 2021

Drawdown Indicators


PIIIBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.73%

-56.78%

-42.95%

Max Drawdown (1Y)

Largest decline over 1 year

-85.08%

-9.10%

-75.98%

Max Drawdown (3Y)

Largest decline over 3 years

-98.91%

-18.90%

-80.01%

Max Drawdown (5Y)

Largest decline over 5 years

-99.73%

-25.43%

-74.30%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-98.28%

-1.58%

-96.70%

Average Drawdown

Average peak-to-trough decline

-73.38%

-10.70%

-62.68%

Ulcer Index

Depth and duration of drawdowns from previous peaks

50.52%

2.14%

+48.38%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of P3 Health Partners Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how P3 Health Partners Inc. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for PIII relative to other companies in the Medical Care Facilities industry. Currently, PIII has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with PIII

Add P3 Health Partners Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with PIII